Medeze Group PCL (MEDEZE)

Currency in THB
6.10
0.00(0.00%)
Closed·
MEDEZE is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
6.106.15
52 wk Range
6.007.35
Key Statistics
Bid/Ask
6.10 / 6.15
Prev. Close
6.1
Open
6.1
Day's Range
6.1-6.15
52 wk Range
6-7.35
Volume
60.4K
Average Volume (3m)
645K
1-Year Change
-12.2302%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MEDEZE Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
8.05
Upside
+31.97%
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Neutral
Moving Averages
Strong Sell

Analyst Ratings

1 Buy
1 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 8.05
(+31.97% Upside)

Earnings

Latest Release
11/08/2026
EPS / Forecast
0.04 / --
Revenue / Forecast
159M / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.13%
Dividend Yield
2.62%
Industry Median 4.22%
Annualised payout
0.16
Paid unevenly
5-Years Growth
-
Growth Streak

MEDEZE Income Statement

Compare MEDEZE to Peers and Sector

Metrics to compare
MEDEZE
Peers
Sector
Relationship
P/E Ratio
46.4x17.4x−0.4x
PEG Ratio
−0.780.030.00
Price/Book
2.2x1.5x2.6x
Price / LTM Sales
9.2x1.7x3.0x
Upside (Analyst Target)
32.0%16.9%56.4%
Fair Value Upside
Unlock33.1%7.9%Unlock

Medeze Group Public Company Limited engages in collection and storage of stem cells for use in medication in Thailand, Vietnam, Cambodia, Philippines, and internationally. The company operates through four segments: Stem Cells; Natural Killer Cells; Others; and Sales of Products. It also provides sorting, cultivation, and development of stem cells; testing services to test the performance and count the number of natural killer cells. In addition, the company is involved in research, develops, and collects data on all types of human cellular activities and medical laboratory tests. Further, the company sells dietary supplements, cosmetics, and dermo cosmetics. Medeze Group Public Company Limited was founded in 2010 and is based in Nakhon Pathom, Thailand.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
370.45M34.69%2.26B
Public Companies & Retail Investors
697.55M65.31%4.26B
Total
1.07B100.00%6.51B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Medeze Holding Co., Ltd33.77%360,700,2572,200,272
Karmarts Public Company Limited0.91%9,750,00059,475

People Also Watch

6.10
EPG
+2.52%
0.880
TPIPL
0.00%
0.25
ESTAR
0.00%

FAQ

What Is the Medeze Group (MEDEZE) Stock Price Today?

The Medeze Group stock price today is 6.10 THB.

What Stock Exchange Does Medeze Group Trade On?

Medeze Group is listed and trades on the Thailand Stock Exchange.

What Is the Stock Symbol for Medeze Group?

The stock symbol for Medeze Group is "MEDEZE."

Does Medeze Group Pay Dividends? What’s The Current Dividend Yield?

The Medeze Group dividend yield is 2.62%.

What Is the Medeze Group Market Cap?

As of today, Medeze Group market cap is 6.51B THB.

What Is Medeze Group's Earnings Per Share (TTM)?

The Medeze Group EPS (TTM) is 0.13.

When Is the Next Medeze Group Earnings Date?

Medeze Group will release its next earnings report on 17/11/2026.

From a Technical Analysis Perspective, Is MEDEZE a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Medeze Group Stock Split?

Medeze Group has split 0 times.

How Many Employees Does Medeze Group Have?

Medeze Group has 200 employees.

What is the current trading status of Medeze Group (MEDEZE)?

As of 02/10/2026, Medeze Group (MEDEZE) is trading at a price of 6.10 THB, with a previous close of 6.10 THB. The stock has fluctuated within a day range of 6.10 THB to 6.15 THB, while its 52-week range spans from 6.00 THB to 7.35 THB.

What Is Medeze Group (MEDEZE) Price Target According to Analysts?

The average 12-month price target for Medeze Group is 8.05 THB, with a high estimate of 9.3 THB and a low estimate of 6.8 THB. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +31.97% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.